| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0165-6147(99)01317-6 |
| P698 | PubMed publication ID | 10354612 |
| P2093 | author name string | Schmidt WJ | |
| Tzschentke TM | |||
| P2860 | cites work | MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. | Q48163465 |
| MK-801 (dizocilpine): synergist and conditioned stimulus in bromocriptine-induced psychomotor sensitization. | Q52202092 | ||
| Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801. | Q52228738 | ||
| MK-801 prevents the development of behavioral sensitization during repeated morphine administration | Q72482348 | ||
| Dizocilpine (MK801): use or abuse? | Q74537557 | ||
| Does the noncompetitive NMDA receptor antagonist dizocilpine (MK801) really block behavioural sensitization associated with repeated drug administration? | Q95442616 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 189-190 | |
| P577 | publication date | 1999-05-01 | |
| P1433 | published in | Trends in Pharmacological Sciences | Q2451474 |
| P1476 | title | Tzschentke and schmidt reply | |
| P478 | volume | 20 |
Search more.